変種とワクチンについて
Nathan D Grubaugh1, Sarah Cobey2
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06510, USA.
Cell
|December 23, 2021
まとめ
より伝染性の高いSARS-CoV-2の変種は,免疫の脱出がなくても,大流行の初期に強く選択されました. 増加する集団免疫は,今後のウイルスの進化と変異の出現に関する予測を複雑にしています.
科学分野:
- ウイルス学
- 流行病学について
- 進化生物学
背景:
- 初期のSARS-CoV-2パンデミックでは,新しい変種が急速に出現した.
- 変種選択の要因を理解することは公衆衛生にとって極めて重要です
- 免疫脱出は既知の要因ですが,他の伝染性の利点も役割を果たす可能性があります.
研究 の 目的:
- パンデミック初期にSARS-CoV-2の変種に対する選択圧力を調査する.
- 免疫脱出なしでの感染性の増加が,変種選択を促すことができるかどうかを判断する.
- 将来の変異動態に対する集団免疫の増加の影響をモデル化すること.
主な方法:
- ウイルスの進化の計算モデルです
- SARS-CoV-2 パンデミック初期における疫学データの分析.
- 異なる免疫シナリオの下での変種選択のシミュレーション
主要な成果:
- 免疫脱出とは無関係な伝染性の増加は,早期の変種選択における重要な要因であった.
- このメカニズムは,以前に観察されたSARS-CoV-2変種の動態を説明します.
- 集団の免疫が増加するにつれて,新たな変異の特徴を予測することはより困難になります.
結論:
- 伝染性はSARS-CoV-2の変種選択の重要な要因であり,特に免疫学的に素朴な集団ではそうである.
- 将来のパンデミックへの備えには,感染可能性と人口免疫の進化の両方を考慮するモデルが必要です.
- ウイルスの進化の軌道を予測するには ダイナミックなモデリング方法が必要です
関連する概念動画
01:51Vaccinations
45.8K
Overview
45.8K
01:30Cancer Vaccines
554
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
554
01:29Microorganisms in Medicine and Therapeutics
461
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
461
00:36Viral Mutations
34.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.6K
00:57Viral Recombination
23.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K
00:42Cross-reactivity
31.7K
Overview
31.7K